Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
PEGS Boston SummitPEGS Boston Summit
Not Confirmed
Not Confirmed
11 May-15 November, 2026
Pharmex Middle EastPharmex Middle East
Not Confirmed
Not Confirmed
26-28 May, 2026
Not Confirmed
Not Confirmed
27-28 May, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS





Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
PEGS Boston SummitPEGS Boston Summit
Industry Trade Show
Not Confirmed
11 May-15 November, 2026
Pharmex Middle EastPharmex Middle East
Industry Trade Show
Not Confirmed
26-28 May, 2026
Industry Trade Show
Not Confirmed
27-28 May, 2026
Digital content

27 Apr 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/zentiva-appeals-eu-court-decision-on-urban-wastewater-directive-302754396.html

09 Apr 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/gtcr-completes-acquisition-of-zentiva-a-leading-european-generics-pharmaceutical-company-302737491.html

16 Mar 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/zentiva-publishes-2025-sustainability-report-reinforcing-commitment-to-people-partners-and-the-planet-302714495.html

23 Feb 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/zentiva-demands-eulevel-stoptheclock-on-the-uwwtd-to-protect-medicine-availability-302694497.html

01 Dec 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/zentiva-expands-into-biologics-with-the-eu-wide-launch-of-its-first-biosimilar-302628251.html

28 Nov 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/demonstrating-accountability-zentiva-receives-prestigious-esg-transparency-award-2025-302628149.html
GDUFA
DMF Review : Complete
Rev. Date : 2013-01-31
Pay. Date : 2013-01-03
DMF Number : 20287
Submission : 2007-02-20
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16530
Submission : 2003-04-08
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 11637
Submission : 1995-08-28
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18018
Submission : 2005-01-21
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 11600
Submission : 1995-08-15
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10374
Submission : 1993-07-21
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18186
Submission : 2005-03-14
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15191
Submission : 2000-12-15
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12404
Submission : 1997-02-28
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16624
Submission : 2003-06-02
Status : Inactive
Type : II

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

CEP/COS
Certificate Numbers : R1-CEP 2002-060 - Rev 07
Status : Valid
Issue Date : 2022-05-17
Type : Chemical
Substance Number : 1688

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

CEP/COS
Certificate Numbers : R1-CEP 2003-223 - Rev 07
Status : Valid
Issue Date : 2022-02-08
Type : Chemical
Substance Number : 718

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

CEP/COS
Certificate Numbers : R0-CEP 2007-043 - Rev 01
Status : Expired
Issue Date : 2009-03-25
Type : Chemical
Substance Number : 2223

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

CEP/COS
Certificate Numbers : R1-CEP 2008-012 - Rev 04
Status : Valid
Issue Date : 2022-05-06
Type : Chemical
Substance Number : 851

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

CEP/COS
Certificate Numbers : CEP 2024-234 - Rev 01
Status : Valid
Issue Date : 2025-12-18
Type : Chemical
Substance Number : 1556

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

CEP/COS
Certificate Numbers : CEP 2023-124 - Rev 01
Status : Valid
Issue Date : 2026-01-19
Type : Chemical
Substance Number : 2020

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

CEP/COS
Certificate Numbers : R1-CEP 2009-121 - Rev 02
Status : Valid
Issue Date : 2021-12-14
Type : Chemical
Substance Number : 2131

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Numbers : CEP 2023-469 - Rev 01
Status : Valid
Issue Date : 2026-01-19
Type : Chemical
Substance Number : 2131

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Date of Issue : 2023-03-11
Valid Till : 2026-10-14
Written Confirmation Number : WC-0133
Address of the Firm : Plot No 3501 to 3515, 6301 to ...

Date of Issue : 2023-03-11
Valid Till : 2026-10-14
Written Confirmation Number : WC-0133
Address of the Firm : Plot No 3501 to 3515, 6301 to ...

Date of Issue : 2023-03-11
Valid Till : 2026-10-14
Written Confirmation Number : WC-0133
Address of the Firm : Plot No 3501 to 3515, 6301 to ...

Date of Issue : 2023-03-11
Valid Till : 2026-10-14
Written Confirmation Number : WC-0133
Address of the Firm : Plot No 3501 to 3515, 6301 to ...

Date of Issue : 2023-03-11
Valid Till : 2026-10-14
Written Confirmation Number : WC-0133
Address of the Firm : Plot No 3501 to 3515, 6301 to ...

Date of Issue : 2023-03-11
Valid Till : 2026-10-14
Written Confirmation Number : WC-0133
Address of the Firm : Plot No 3501 to 3515, 6301 to ...

Date of Issue : 2023-03-11
Valid Till : 2026-10-14
Written Confirmation Number : WC-0133
Address of the Firm : Plot No 3501 to 3515, 6301 to ...

Date of Issue : 2023-03-11
Valid Till : 2026-10-14
Written Confirmation Number : WC-0133
Address of the Firm : Plot No 3501 to 3515, 6301 to ...

Date of Issue : 2023-03-11
Valid Till : 2026-10-14
Written Confirmation Number : WC-0133
Address of the Firm : Plot No 3501 to 3515, 6301 to ...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Registrant Name : Handok Co., Ltd.
Registration Date : 2021-04-16
Registration Number : 20210416-209-J-939
Manufacturer Name : Zentiva Private Limited@BAKUL ...
Manufacturer Address : Plot No. 3501 to 3515, 6301 to 6313 & 16 meter road/c, GIDC Estate, Ankleshwar – 39...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Under the acquisition, Methylphenidate HCl, a small molecule product targeting Dopamine transporter and Norepinephrine transporter, will advance treatment for Attention Deficit Disorder with Hyperactivity.
Lead Product(s): Methylphenidate Hydrochloride
Therapeutic Area: Psychiatry/Psychology Brand Name: Affenid XL
Study Phase: Approved FDFProduct Type: Controlled Substance
Sponsor: GTCR
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition April 09, 2026

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Methylphenidate Hydrochloride
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : GTCR
Deal Size : Undisclosed
Deal Type : Acquisition
GTCR Acquires Zentiva, Top European Generics Pharma Company
Details : Under the acquisition, Methylphenidate HCl, a small molecule product targeting Dopamine transporter and Norepinephrine transporter, will advance treatment for Attention Deficit Disorder with Hyperactivity.
Product Name : Affenid XL
Product Type : Controlled Substance
Upfront Cash : Undisclosed
April 09, 2026

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Phytosterol is a plant extract/herbal drug, which is currently being evaluated in clinical studies for the treatment of hyperlipoproteinemias.
Lead Product(s): Phytosterols,Artichoke Extract,Vitamin B1
Therapeutic Area: Endocrinology Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Plant Extract/Herbal
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable February 12, 2026

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Phytosterols,Artichoke Extract,Vitamin B1
Therapeutic Area : Endocrinology
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Phytosterol is a plant extract/herbal drug, which is currently being evaluated in clinical studies for the treatment of hyperlipoproteinemias.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
February 12, 2026

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
An antibody, unconjugated, is showing promising results in treating bone conditions.
Lead Product(s): Undisclosed
Therapeutic Area: Musculoskeletal Brand Name: Undisclosed
Study Phase: Approved FDFProduct Type: Antibody, Unconjugated
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable December 01, 2025

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Musculoskeletal
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Zentiva Launches First Biosimilar in EU
Details : An antibody, unconjugated, is showing promising results in treating bone conditions.
Product Name : Undisclosed
Product Type : Antibody, Unconjugated
Upfront Cash : Inapplicable
December 01, 2025

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
GTCR’s acquisition of Zentiva includes its portfolio, ongoing R&D, and pipeline, continuing the company’s expansion of generics and development projects in Europe.
Lead Product(s): Methylphenidate Hydrochloride
Therapeutic Area: Psychiatry/Psychology Brand Name: Affenid XL
Study Phase: Approved FDFProduct Type: Miscellaneous
Sponsor: GTCR
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition September 11, 2025

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Methylphenidate Hydrochloride
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : GTCR
Deal Size : Undisclosed
Deal Type : Acquisition
Zentiva Announces Sale from Advent to GTCR
Details : GTCR’s acquisition of Zentiva includes its portfolio, ongoing R&D, and pipeline, continuing the company’s expansion of generics and development projects in Europe.
Product Name : Affenid XL
Product Type : Miscellaneous
Upfront Cash : Undisclosed
September 11, 2025

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Zentiva holds a broad portfolio of generic and biosimilar products, including Affenid XL (methylphenidate hydrochloride) for the treatment of Attention-Deficit/Hyperactivity Disorder.
Lead Product(s): Methylphenidate Hydrochloride
Therapeutic Area: Psychiatry/Psychology Brand Name: Affenid XL
Study Phase: Approved FDFProduct Type: Miscellaneous
Sponsor: Aurobindo Pharma Limited
Deal Size: $5,500.0 million Upfront Cash: Undisclosed
Deal Type: Acquisition August 20, 2025

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Methylphenidate Hydrochloride
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Aurobindo Pharma Limited
Deal Size : $5,500.0 million
Deal Type : Acquisition
Aurobindo Pharma closing in on $5.5b Zentiva buyout
Details : Zentiva holds a broad portfolio of generic and biosimilar products, including Affenid XL (methylphenidate hydrochloride) for the treatment of Attention-Deficit/Hyperactivity Disorder.
Product Name : Affenid XL
Product Type : Miscellaneous
Upfront Cash : Undisclosed
August 20, 2025

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Under the licensing agreement, Zentiva will hold the rights for the commercialization and manufacturing of linaprazan glurate, in Europe.
Lead Product(s): Linaprazan Glurate
Therapeutic Area: Gastroenterology Brand Name: Undisclosed
Study Phase: Phase IIProduct Type: Miscellaneous
Recipient: Cinclus Pharma
Deal Size: $249.2 million Upfront Cash: $14.7 million
Deal Type: Licensing Agreement May 22, 2025

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Linaprazan Glurate
Therapeutic Area : Gastroenterology
Highest Development Status : Phase II
Recipient : Cinclus Pharma
Deal Size : $249.2 million
Deal Type : Licensing Agreement
Zentiva Inks €220M Deal for Former AstraZeneca GI Drug in Europe
Details : Under the licensing agreement, Zentiva will hold the rights for the commercialization and manufacturing of linaprazan glurate, in Europe.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : $14.7 million
May 22, 2025

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Raltegravir is an approved, small molecule, HIV-1 integrase inhibitor, available as a film coated tablet for the treatment of HIV in adult and paediatric patients weighing at least 40kg.
Lead Product(s): Raltegravir Potassium
Therapeutic Area: Infections and Infectious Diseases Brand Name: Raltegravir-Generic
Study Phase: Approved FDFProduct Type: Miscellaneous
Recipient: Lupin Ltd
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable July 22, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Raltegravir Potassium
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved FDF
Recipient : Lupin Ltd
Deal Size : Inapplicable
Deal Type : Inapplicable
Generic HIV raltegravir medicines approved
Details : Raltegravir is an approved, small molecule, HIV-1 integrase inhibitor, available as a film coated tablet for the treatment of HIV in adult and paediatric patients weighing at least 40kg.
Product Name : Raltegravir-Generic
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 22, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Liraglutide-Generic is a glucagon-like peptide-1 (GLP-1) receptor agonist, which is indicated for the treatment of patients with type 2 diabetes mellitus.
Lead Product(s): Liraglutide
Therapeutic Area: Endocrinology Brand Name: Liraglutide-Generic
Study Phase: Approved FDFProduct Type: Peptide, Unconjugated
Recipient: Biocon
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable March 28, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Liraglutide
Therapeutic Area : Endocrinology
Highest Development Status : Approved FDF
Recipient : Biocon
Deal Size : Inapplicable
Deal Type : Inapplicable
Biocon to Obtain Approval for Diabetes Drug, Liraglutide in UK
Details : Liraglutide-Generic is a glucagon-like peptide-1 (GLP-1) receptor agonist, which is indicated for the treatment of patients with type 2 diabetes mellitus.
Product Name : Liraglutide-Generic
Product Type : Peptide, Unconjugated
Upfront Cash : Inapplicable
March 28, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Under the terms of collaboration, Zentiva will complement their product offering with the support of longstanding partners Adalvo with new molecules in a variety of therapeutical areas like Respiratory, CNS and Dermatology.
Lead Product(s): Undisclosed
Therapeutic Area: Pulmonary/Respiratory Diseases Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Undisclosed
Recipient: Adalvo
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Expanded Collaboration January 09, 2023

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Undisclosed
Recipient : Adalvo
Deal Size : Undisclosed
Deal Type : Expanded Collaboration
Details : Under the terms of collaboration, Zentiva will complement their product offering with the support of longstanding partners Adalvo with new molecules in a variety of therapeutical areas like Respiratory, CNS and Dermatology.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
January 09, 2023

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Through this acquisition, Zentiva will significantly increase its position in the Hospital sector and more specifically in the Oncology area with some value-added 16 products complementing the products recently launched.
Lead Product(s): Undisclosed
Therapeutic Area: Oncology Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Undisclosed
Recipient: Tillomed Laboratories Ltd
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition December 16, 2022

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Undisclosed
Recipient : Tillomed Laboratories Ltd
Deal Size : Undisclosed
Deal Type : Acquisition
Zentiva Completes Major Product Acquisition from Tillomed Spain
Details : Through this acquisition, Zentiva will significantly increase its position in the Hospital sector and more specifically in the Oncology area with some value-added 16 products complementing the products recently launched.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
December 16, 2022

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Approved
Registration Country : Sweden
Dosage Form : Film Coated Tablet
Brand Name : Sertralin Zentiva
Dosage Strength : 25mg
Packaging :
Approval Date : 06-10-2021
Application Number : 2.02E+13
Regulatory Info : Approved
Registration Country : Sweden

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Approved
Registration Country : Sweden
Dosage Form : Film Coated Tablet
Brand Name : Sertralin Zentiva
Dosage Strength : 50mg
Packaging :
Approval Date : 15-05-2024
Application Number : 2.02E+13
Regulatory Info : Approved
Registration Country : Sweden

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Approved
Registration Country : Sweden
Dosage Form : Film Coated Tablet
Brand Name : Sertralin Zentiva
Dosage Strength : 100mg
Packaging :
Approval Date : 15-05-2024
Application Number : 2.02E+13
Regulatory Info : Approved
Registration Country : Sweden

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Authorized
Registration Country : Spain
Dosage Form : Film Coated Tablet
Brand Name : Abacavir Zentiva
Dosage Strength : 300MG
Packaging :
Approval Date : 30-07-2021
Application Number : 86115
Regulatory Info : Authorized
Registration Country : Spain

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Czech Republic
Dosage Form : Film Coated Tablet
Brand Name :
Dosage Strength : 600MG; 300MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Czech Republic

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Deregistered
Registration Country : Sweden
Dosage Form : Film Coated Tablet
Brand Name : Abacavir/Lamivudine Zenti...
Dosage Strength : 600mg;300mg
Packaging :
Approval Date : 07-08-2020
Application Number : 2.02E+13
Regulatory Info : Deregistered
Registration Country : Sweden

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Prescription
Registration Country : Estonia
Dosage Form : Film-Coated Tablet
Brand Name : Abiraterone Zentiva
Dosage Strength : 500mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Prescription
Registration Country : Estonia

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Czech Republic
Dosage Form : Film Coated Tablet
Brand Name :
Dosage Strength : 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Czech Republic

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Authorized
Registration Country : Spain
Dosage Form : Tablet
Brand Name : Abiraterona Zentiva
Dosage Strength : 250MG
Packaging :
Approval Date : 16-03-2021
Application Number : 85849
Regulatory Info : Authorized
Registration Country : Spain

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Authorized
Registration Country : Spain
Dosage Form : Film Coated Tablet
Brand Name : Abiraterona Zentiva
Dosage Strength : 500MG
Packaging :
Approval Date : 16-03-2021
Application Number : 85850
Regulatory Info : Authorized
Registration Country : Spain

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Approved
Registration Country : Sweden
Dosage Form : Film Coated Tablet
Dosage Strength : 25mg
Packaging :
Brand Name : Sertralin Zentiva
Approval Date : 06-10-2021
Application Number : 2.02E+13
Regulatory Info : Approved
Registration Country : Sweden

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Approved
Registration Country : Sweden
Dosage Form : Film Coated Tablet
Dosage Strength : 50mg
Packaging :
Brand Name : Sertralin Zentiva
Approval Date : 15-05-2024
Application Number : 2.02E+13
Regulatory Info : Approved
Registration Country : Sweden

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Approved
Registration Country : Sweden
Dosage Form : Film Coated Tablet
Dosage Strength : 100mg
Packaging :
Brand Name : Sertralin Zentiva
Approval Date : 15-05-2024
Application Number : 2.02E+13
Regulatory Info : Approved
Registration Country : Sweden

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Authorized
Registration Country : Spain
Dosage Form : Film Coated Tablet
Dosage Strength : 300MG
Packaging :
Brand Name : Abacavir Zentiva
Approval Date : 30-07-2021
Application Number : 86115
Regulatory Info : Authorized
Registration Country : Spain

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Deregistered
Registration Country : Sweden
Dosage Form : Film Coated Tablet
Dosage Strength : 600mg;300mg
Packaging :
Brand Name : Abacavir/Lamivudine Zentiva
Approval Date : 07-08-2020
Application Number : 2.02E+13
Regulatory Info : Deregistered
Registration Country : Sweden

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Prescription
Registration Country : Estonia
Dosage Form : Film-Coated Tablet
Dosage Strength : 500mg
Packaging :
Brand Name : Abiraterone Zentiva
Approval Date :
Application Number :
Regulatory Info : Prescription
Registration Country : Estonia

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Authorized
Registration Country : Spain
Dosage Form : Tablet
Dosage Strength : 250MG
Packaging :
Brand Name : Abiraterona Zentiva
Approval Date : 16-03-2021
Application Number : 85849
Regulatory Info : Authorized
Registration Country : Spain

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Authorized
Registration Country : Spain
Dosage Form : Film Coated Tablet
Dosage Strength : 500MG
Packaging :
Brand Name : Abiraterona Zentiva
Approval Date : 16-03-2021
Application Number : 85850
Regulatory Info : Authorized
Registration Country : Spain

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Prescription
Registration Country : Denmark
Dosage Form : Film Coated Tablet
Dosage Strength : 500mg
Packaging :
Brand Name : Abiraterone \"Zentiva\"
Approval Date : 11-07-2022
Application Number : 28106525920
Regulatory Info : Prescription
Registration Country : Denmark

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Approved
Registration Country : Sweden
Dosage Form : Film Coated Tablet
Dosage Strength : 500mg
Packaging :
Brand Name : Abiraterone Zentiva
Approval Date : 21-12-2021
Application Number : 2.02E+13
Regulatory Info : Approved
Registration Country : Sweden

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]REF. STANDARDS & IMPURITIES
Inspections and registrations
Country : Romania
City/Region : Bucarest
Audit Date : 2024-01-10
Audit Type : On-Site
Country : India
City/Region : Ankleshwar
Audit Date : Aug-25
Audit Type : On-Site
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
Zentiva is a supplier offers 19 products (APIs, Excipients or Intermediates).
Find Articaine Hydrochloride bulk with DMF, CEP, WC offered by Zentiva
Find Glibenclamide bulk with DMF, CEP, WC offered by Zentiva
Find Pentoxifylline bulk with CEP, WC offered by Zentiva
Find Tamsulosin bulk with CEP, WC offered by Zentiva
Find Agomelatine bulk with WC offered by Zentiva
Find Glibenclamide bulk with WC offered by Zentiva
Find Pheniramine Maleate bulk with WC offered by Zentiva
Find Piretanide bulk with CEP offered by Zentiva
Find Ramipril bulk with WC offered by Zentiva
Find Rilmenidine Phosphate bulk with CEP offered by Zentiva
Find Tamsulosin bulk with CEP offered by Zentiva
Find Tenofovir Alafenamide bulk with WC offered by Zentiva
Find Carvedilol bulk offered by Zentiva
Find Glimepiride bulk offered by Zentiva
Find Metipranolol HCl bulk offered by Zentiva
Find Metoprolol Succinate bulk offered by Zentiva
Find Tetrahydrozoline bulk offered by Zentiva
Find Tramadol Hydrochloride bulk offered by Zentiva
Find Zolpidem Tartrate bulk offered by Zentiva